GlassScriptPhysician profile
Raj Patel
NPI 1609221787
$119,822.18
in general payments reported to CMS, 2019-2025
40 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.85 · 2020: $76K · 2021: $1,637 · 2022: $2,504 · 2023: $9,875 · 2024: $10K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $10K · Consulting Fee: $3,150 · Travel and Lodging: $1,050 · Entertainment: $35.66 · Education: $19.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,031.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,150.00 |
| Food and Beverage | $10,476.96 |
| Consulting Fee | $3,150.00 |
| Travel and Lodging | $1,049.92 |
| Entertainment | $35.66 |
| Education | $19.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $79,665.70 | 2020-2025 | Proclaim, Eterna, Infinity |
| Medtronic USA, INC. | $20,000.00 | 2020 | |
| Boston Scientific Corporation | $10,912.47 | 2020-2023 | |
| Medtronic, INC. | $3,558.93 | 2021-2025 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Wenzel Spine, INC. | $938.86 | 2024-2025 | Primalok, Varilift, Varilift |
| Spinal Simplicity, LLC | $644.94 | 2024-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $639.96 | 2021-2023 | Intracept |
| Vertos Medical, INC. | $451.03 | 2022-2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $364.18 | 2019-2024 | Prialt |
| Nevro Corp. | $327.66 | 2020-2022 | |
| Saluda Medical Americas, INC. | $284.51 | 2023-2025 | Evoke Scs, Evoke |
| Abbvie INC. | $225.90 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $225.35 | 2022-2025 | Relistor, Trulance |
| Globus Medical, INC. | $193.32 | 2025 | Senza |
| Bioventus LLC | $128.56 | 2023-2024 | Durolane, Gelsyn-3, Durolane |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $121.84 | 2021 | |
| Preventice Services, LLC | $110.64 | 2020 | |
| Si-Bone, INC. | $107.82 | 2022-2025 | |
| Nalu Medical, INC. | $98.01 | 2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $89.23 | 2022-2024 | Ztlido |
| E.R. Squibb & Sons, L.L.C. | $88.33 | 2024 | |
| Pfizer INC. | $81.38 | 2023-2024 | |
| Curonix LLC | $54.33 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Arbor Pharmaceuticals, INC. | $50.73 | 2022 | |
| Mml US, INC. | $48.34 | 2023 | Reactiv8 |
| Ultragenyx Pharmaceutical INC. | $45.78 | 2024 | Crysvita |
| Biohaven Pharmaceutical Holding Company LTD. | $44.67 | 2022 | |
| Collegium Pharmaceutical, INC. | $44.01 | 2023 | Belbuca |
| Spr Therapeutics, INC | $36.59 | 2025 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $35.66 | 2024 | |
| Convatec INC. | $32.37 | 2024-2025 | |
| Axsome Therapeutics, INC. | $25.59 | 2025 | Symbravo |
| Zimmer Biomet Holdings, INC. | $20.70 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Ibsa Pharma INC. | $20.52 | 2023 | Tirosint, Licart |
| Janssen Pharmaceuticals, INC | $19.35 | 2023 | Xarelto |
| Depuy Synthes Sales INC. | $19.14 | 2022 | |
| Protega Pharmaceutials INC | $18.36 | 2025 | Roxybond |
| Azurity Pharmaceuticals, INC. | $16.52 | 2023 | Horizant |
| Biohaven Pharmaceuticals, INC. | $15.69 | 2021 | |
| Averitas Pharma INC. | $15.21 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.